Sofwave
- Sofwave Riding the Weight-Loss Drug Boom
"Excluding legal expenses, we turned to operating profitability in 2024," say Shimon Eckhouse, Chairman and Founder, and Assaf Korner, CFO of Sofwave. On Asian markets awaiting regulatory approvals: "The Chinese market is expected to be the same size as the U.S. market. Everything is ready—we're just waiting for final approvals, which we hope will come soon."
Interview